Question 25897 — maternity health insurance

Summary

Mr. Laurent Furst, MP for Bas-Rhin, draws the attention of the Minister of Solidarity and Health to the announced delisting of ELMIRON, intended to treat patients suffering in particular from interstitial cystitis. Indeed, nearly 300 patients in France are currently benefiting from this treatment which has considerably improved their quality of life and which seems to be the only one currently available orally. If the High Authority of health was able to estimate that the medical benefit provided was low in view of the price of this medicine, it seems essential to patients to relieve them of unbearable pain on a daily basis. Also, and while waiting to be able to offer a replacement treatment, it would seem necessary to reverse the decision to defund this medication from February 1, 2020, so that people benefiting from it can continue to live with dignity. He would therefore like to know his intentions on this issue.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.